Showing results (581-590 of 655) with videos related to

Sort By:
Pageof 66
Journal of Translational Medicine|August 22, 2025
In silico prediction of optimal multifactorial intervention in chronic kidney diseaseAgnieszka Latosinska, Ioanna K Mina, Thi Minh Nghia Nguyen, et al.
European Heart Journal|August 30, 2024
Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the FLOW trialKenneth W Mahaffey, Katherine R Tuttle, Mustafa Arici, et al.
Elife|December 11, 2019
Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data miningIsa Kristina Kirk, Christian Simon, Karina Banasik, et al.
American Journal of Nephrology|October 14, 2020
A Targeted Multiomics Approach to Identify Biomarkers Associated with Rapid eGFR Decline in Type 1 DiabetesChristine P Limonte, Erkka Valo, Daniel Montemayor, et al.
Journal of the American College of Cardiology|June 3, 2026
Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease: FLOW Trial Cardiovascular Subgroup AnalysesKatherine R Tuttle, George L Bakris, Florian M M Baeres, et al.
Frontiers in Endocrinology|March 17, 2023
Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in EuropeansNicoline Uglebjerg, Fariba Ahmadizar, Dina M Aly, et al.
Kidney International Reports|November 14, 2017
Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic BiomarkerClaudia Pontillo, Zhen-Yu Zhang, Joost P Schanstra, et al.
Kidney International|October 22, 2022
Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidencePeter Rossing, M Luiza Caramori, Juliana C N Chan, et al.
Nature Medicine|September 1, 2024
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomesMuthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett, et al.
Diabetes Care|November 21, 2018
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced NephropathyJan Skupien, Adam M Smiles, Erkka Valo, et al.
Pageof 66